Regulation of Dendritic Cell Migration to the Draining Lymph Node
Open accessThe DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Antigen-pulsed dendritic cells (DCs) are used as natural adjuvants for vaccination, but the factors that influence the efficacy of this treatment are poorly understood. We investigated the parameters that affect the migration of subcutaneously injected mouse-mature DCs to the draining lymph node. We found that the efficiency of DC migration varied with the number of injected DCs and that CCR7+/+ DCs migrating to the draining lymph node, but not CCR7-/- DCs that failed to do so, efficiently induced a rapid increase in lymph node cellularity, which was observed before the onset of T cell proliferation. We also report that DC migration could be increased up to 10-fold by preinjection of inflammatory cytokines that increased the expression of the CCR7 ligand CCL21 in lymphatic endothelial cells. The magnitude and quality of CD4+ T cell response was proportional to the number of antigen-carrying DCs that reached the lymph node and could be boosted up to 40-fold by preinjection of tumor necrosis factor that conditioned the tissue for increased DC migration. These results indicate that DC number and tissue inflammation are critical parameters for DC-based vaccination.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Mouse DCs start to enter the regional lymph node 18 hours after inoculation in the skin, reaching a maximum within 72 hours.50,51”
From Modification of antigen-encoding RNA increases stability, translational efficacy, and T-cell stimulatory capacity of dendritic cells (2006) · cites this paper as [50]
Experimental — accuracy not yet measuredIn the citing paper
“besides their critical role for priming T cells in lymph nodes (Martin-Fontecha et al., 2003)”
From Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12 (2018) · cites this paper as Martin-Fontecha et al., 2003
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dendritic cells and the control of immunity
Banchereau, J., & Steinman, R. M. (1998) · Nature · doi:10.1038/32588 · Cited by 14,336 · cited 1×
“Tissue-resident DCs and DC precursors, such as monocytes or immature DCs recruited from the blood, are stimulated by microbial products and inflammatory cytokines to undergo a coordinately regulated process of maturation and migration (1).”
The Biology of Chemokines and their Receptors
Rossi, D., & Zlotnik, A. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.217 · Cited by 2,410 · cited 1×
“The finding that DC migration can be boosted by inflammatory stimuli through up-regulation of CCL21 on lymphatic endothelial cells was unexpected, because CCL21 has been considered the prototype of constitutive chemokines (27).”
Förster, R., Schubel, A., Breitfeld, D., Kremmer, E., Renner-Müller, I., Wolf, E., & Lipp, M. (1999) · Cell · doi:10.1016/s0092-8674(00)80059-8 · Cited by 2,367 · cited 5×
“Lack of CCR7 or its ligands leads to dramatic changes in DC and lymphocyte traffic and abnormal lymph node architecture (8, 9).”
InfluentialSelf-citationAlteration of Lymphocyte Trafficking by Sphingosine-1-Phosphate Receptor Agonists
Mandala, S., Hajdu, R., Bergstrom, J., Quackenbush, E., Xie, J., Milligan, J., Thornton, R., Shei, G.-J., Card, D., Keohane, C., et al. (2002) · Science · doi:10.1126/science.1070238 · Cited by 1,690 · cited 5×
“The fact that CCR7 / DCs, which are incapable of migrating to the lymph node, do not cause lymph node congestion indicates that this phenomenon is mediated by mature DCs that have reached the lymph node through mechanisms that still need to be identified but might be related to release of chemokines or S1P.”
InfluentialDieu, M.-C., Vanbervliet, B., Vicari, A., Bridon, J.-M., Oldham, E., Aït-Yahia, S., Brière, F., Zlotnik, A., Lebecque, S., & Caux, C. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.2.373 · Cited by 1,425 · cited 1×
“Immature DCs express receptors for inflammatory chemokines and, upon induction of maturation, up-regulate CCR7, a chemokine receptor that drives their migration to the lymphatics (2, 3).”
Bonifaz, L., Bonnyay, D., Mahnke, K., Rivera, M., Nussenzweig, M. C., & Steinman, R. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021598 · Cited by 1,306
Rapid and coordinated switch in chemokine receptor expression during dendritic cell maturation
Sallusto, F., Schaerli, P., Loetscher, P., Schaniel, C., Lenig, D., Mackay, C. R., Qin, S., & Lanzavecchia, A. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199809)28:09<2760::aid-immu2760>3.0.co;2-n · Cited by 1,183 · cited 1×
“Immature DCs express receptors for inflammatory chemokines and, upon induction of maturation, up-regulate CCR7, a chemokine receptor that drives their migration to the lymphatics (2, 3).”
Gunn, M. D., Kyuwa, S., Tam, C., Kakiuchi, T., Matsuzawa, A., Williams, L. T., & Nakano, H. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.3.451 · Cited by 1,019 · cited 2×
“In plt/plt mice, which carry a spontaneous mutation that abolishes CCL19 expression and restricts CCL21 expression to the lymphatic endothelium, DCs and naive T cells fail to enter the T cell zone of secondary lymphoid organs (9, 10).”
Gunn, M. D., Tangemann, K., Tam, C., Cyster, J. G., Rosen, S. D., & Williams, L. T. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.1.258 · Cited by 1,001
Kurts, C., Kosaka, H., Carbone, F. R., Miller, J. F. A. P., & Heath, W. R. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.2.239 · Cited by 706
Cited by
Items 201–300 of 888
Impact of CCR7 on Priming and Distribution of Antiviral Effector and Memory CTL
Junt, T., Scandella, E., Förster, R., Krebs, P., Krautwald, S., Lipp, M., Hengartner, H., & Ludewig, B. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6684 · Cited by 84
“Furthermore, a recent study reported that peripheral CCL21 caused lymph node congestion and augmented the initiation of T cell responses during inflammation (32).”
BackgroundSelf-citationSimultaneous in vivo tracking of dendritic cells and priming of an antigen-specific immune response
Noh, Y., Jang, Y., Ahn, K. J., Lim, Y. T., & Chung, B. H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.05.013 · Cited by 83
Fisher, D. T., Chen, Q., Appenheimer, M. M., Skitzki, J. J., Wang, W., Odunsi, K. O., & Evans, S. S. (2006) · Immunological Investigations · doi:10.1080/08820130600745430 · Cited by 84
“However, introduction of antigen-pulsed mature DC into the skin leads to an increase in the accumulation of NK cells and T cells in dLN through an L-selectin-dependent, CCR7-independent mechanism (Martin-Fontecha et al., 2003, 2004; Sallusto and Mackay, 2004).”
BackgroundThe inflammatory response of lymphatic endothelium
Aebischer, D., Iolyeva, M. E., & Halin, C. (2013) · Angiogenesis · doi:10.1007/s10456-013-9404-3 · Cited by 86
Schmid, M. A., Takizawa, H., Baumjohann, D. R., Saito, Y., & Manz, M. G. (2011) · Blood · doi:10.1182/blood-2011-03-344960 · Cited by 76
Giermasz, A. S., Urban, J. A., Nakamura, Y., Watchmaker, P. B., Cumberland, R. L., Gooding, W. E., & Kaliński, P. (2009) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-008-0648-5 · Cited by 81
“It was previously shown that mouse antigen-carrying DCs can be found in draining LN within hours [8, 28, 41], while”
Dendritic Cells in Cancer Immunotherapy
Vulink, A. J. E., Radford, K. J., Melief, C. J. M., & Hart, D. N. J. (2007) · Advances in cancer research · doi:10.1016/s0065-230x(07)99006-5 · Cited by 88
Dendritic Cells: A Critical Player in Cancer Therapy?
Palucka, A. K., Ueno, H., Fay, J. W., & Banchereau, J. (2008) · Journal of Immunotherapy · doi:10.1097/cji.0b013e31818403bc · Cited by 87
“A mouse study showed improved DC migration by conditioning the injection site with TNF.(100) Intranodal injection may result in DCs getting trapped in the fat tissue surrounding the lymph node.”
BackgroundEnhancement of Dendritic Cells as Vaccines for Cancer
Turnis, M. E., & Rooney, C. M. (2010) · Immunotherapy · doi:10.2217/imt.10.56 · Cited by 90
Lee, S. B., Ahn, S. B., Lee, S.-W., Jeong, S. Y., GhilSuk, Y., Ahn, B., Kim, E., Jeong, H., Lee, J., Lim, D., et al. (2016) · NPG Asia Materials · doi:10.1038/am.2016.80 · Cited by 81
Noh, Y., Lim, Y. T., & Chung, B. H. (2008) · The FASEB Journal · doi:10.1096/fj.08-112896 · Cited by 84
“But preconditioning of the injection site with proinflammatory cytokines such as TNF- led to enhanced DC migration to the draining lymph nodes (in mice) by up to 10-fold (8, 39) To enhance the DC migration rate, therefore, the DC injection site was preconditioned with TNF- for 24 h.”
BackgroundDarmanin, S., Chen, J., Zhao, S., Cui, H., Shirkoohi, R., Kubo, N., Kuge, Y., Tamaki, N., Nakagawa, K., Hamada, J.-I., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.7.4616 · Cited by 74
“Because murine studies show that DC migration correlates with T cell proliferation (30), it is not wrong to assume that T cell distribution and tumor control might be linked to injection route-dependent localization of DCs in lymphoid organs.”
BackgroundLactate Exposure Promotes Immunosuppressive Phenotypes in Innate Immune Cells
Sangsuwan, R., Thuamsang, B., Pacifici, N. J., Allen, R. P., Han, H., Miakicheva, S., & Lewis, J. S. (2020) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-020-00652-x · Cited by 82
A key role for CCR7 in establishing central and peripheral tolerance
Worbs, T., & Förster, R. (2007) · Trends in Immunology · doi:10.1016/j.it.2007.04.002 · Cited by 84
Saban, D. R. (2014) · The Ocular Surface · doi:10.1016/j.jtos.2013.10.007 · Cited by 81
“endothelial cells of terminal lymphatic vessels of nonlymphoid tissues upregulate CCR7 ligands, and thus establish a chemotactic gradient by which CCR7 expressing DCs follow toward and into the lymphatic vessels (Figure 2).(8,11,44) Lymphatic drainage, which carries these DCs, is eventually collected into afferent lym…”
Granulocytes as modulators of dendritic cell function
Breedveld, A. C., Kormelink, T. G., van Egmond, M., & de Jong, E. C. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.4mr0217-048rr · Cited by 84
“In line with earlier observations [179, 180], mast cell-derived TNF-a enhanced CCR7 expression on mouse CD11bCD11cMHC-II DCs in the dermis, as well as CCL21 expression in draining lymph nodes, thereby promoting migration of activated DCs to draining lymph nodes [177].”
ResultT cells and their partners: the chemokine dating agency
Viola, A., Contento, R. L., & Molon, B. (2006) · Trends in Immunology · doi:10.1016/j.it.2006.07.004 · Cited by 76
The Interplay Between Lymphatic Vessels and Chemokines
Farnsworth, R. H., Karnezis, T., Maciburko, S. J., Mueller, S. N., & Stacker, S. A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00518 · Cited by 79
DCs and CD40-activated B cells: current and future avenues to cellular cancer immunotherapy
Schultze, J. L., Grabbe, S., & von-Bergwelt-Baildon, M. (2004) · Trends in Immunology · doi:10.1016/j.it.2004.09.016 · Cited by 75
Insights in the immunobiology of glioblastoma
Strepkos, D., Markouli, M., Κλώνου, Α., Piperi, C., & Papavassiliou, A. G. (2019) · Journal of Molecular Medicine · doi:10.1007/s00109-019-01835-4 · Cited by 79
“Furthermore, IL-8 acts as a powerful activator for angiogenesis by regulating the migration of endothelial cells and their survival and proliferation [42].”
BackgroundCharacteristics of lymphatic endothelial cells in physiological and pathological conditions.
Ji, R. C. (2005) · PubMed · doi:10.14670/hh-20.155 · Cited by 85
Tumor Cell Loaded Type-1 Polarized Dendritic Cells Induce Th1-Mediated Tumor Immunity
Hokey, D. A., Larregina, A. T., Erdös, G., Watkins, S. C., & Falo, L. D. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1692 · Cited by 74
“Given the transit times reported for the trafficking of skin injected dendritic cells to the draining lymph nodes in murine and human systems, it is plausible that cutaneously given dendritic cells will engage CD40Lexpressing T cells before exhaustion (43, 44).”
BackgroundHauser, M. A., Kindinger, I., Laufer, J. M., Späte, A., Bucher, D., Vanes, S. L., Krueger, W. A., Wittmann, V., & Legler, D. F. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.2vma0915-432rr · Cited by 80
“Upon pathogen encounter, mature DCs migrate into lymphoid organs, resulting in lymph node conditioning [71], cleavage of CCL21, and secretion of glycosidases.”
BackgroundFontes, J. A., Barin, J. G., Talor, M. V., Stickel, N., Schaub, J. A., Rose, N. R., & Čiháková, D. (2017) · Immunity Inflammation and Disease · doi:10.1002/iid3.155 · Cited by 82
“It has also been shown that lymphatic CCL21 expression can be upregulated by inflammatory cytokines [32], confirming our observation that IL-6 mediates expression of both CCL21 ligand and its CCR7 receptor.”
BackgroundArasa, J., Collado‐Díaz, V., Kritikos, I., Medina-Sanchez, J. D., Friess, M. C., Sigmund, E. C., Schineis, P., Hunter, M. C., Tacconi, C., Paterson, N., et al. (2021) · The Journal of Experimental Medicine · doi:10.1084/jem.20201413 · Cited by 77
Control of Dendritic Cell Function Within the Tumour Microenvironment
Hari‐Gupta, Y., Khanom, A., & Acton, S. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.733800 · Cited by 78
Lymphoid stroma in the initiation and control of immune responses
Mueller, S. N., & Ahmed, R. (2008) · Immunological Reviews · doi:10.1111/j.1600-065x.2008.00657.x · Cited by 86
“Yanagawa Y, Onoe K. CCR7 ligands induce rapid endocytosis in mature dendritic cells with concomitant up-regulation of Cdc42 and Rac activities.”
BackgroundInfluentialPulecio, J., Tagliani, E., Scholer, A., Prete, F., Fetler, L., Burrone, Ó. R., & Benvenuti, F. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.2.1135 · Cited by 73
“DCs already in LN affect the behavior of incoming DCs (31) thus, the discrepancy may depend on the fact that we compared localization of equal absolute numbers of WT and WASp DCs.”
ResultDendritic cells adhere to and transmigrate across lymphatic endothelium in response to IFN‐α
Rouzaut, A., Garasa, S., Teijeira, Á., González, I., Martínez‐Forero, I., Suárez, N., Larrea, E., Alfaro, C., Palazón, A., Dubrot, J., et al. (2010) · European Journal of Immunology · doi:10.1002/eji.201040523 · Cited by 72
Martin‐Fontecha, A., Baumjohann, D., Guarda, G., Reboldi, A., Hons, M., Lanzavecchia, A., & Sallusto, F. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20081212 · Cited by 72
Self-citationTaking the lymphatic route: dendritic cell migration to draining lymph nodes
Teijeira, Á., Russo, E., & Halin, C. (2014) · Seminars in Immunopathology · doi:10.1007/s00281-013-0410-8 · Cited by 83
Interferons Induce CXCR3-cognate Chemokine Production by Human Metastatic Melanoma
Dengel, L. T., Norrod, A. G., Gregory, B. L., Clancy‐Thompson, E., Burdick, M. D., Strieter, R. M., Slingluff, C. L., & Mullins, D. W. (2010) · Journal of Immunotherapy · doi:10.1097/cji.0b013e3181fb045d · Cited by 71
Andresen, A. M. S., Ferreira, K. S., de Almeida, S. R., Nosanchuk, J. D., Travassos, L. R., & Taborda, C. P. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05414-11 · Cited by 71
“We studied the subcutaneous route, as previous reports show that injection of DCs into footpads resulted in the migration of significant numbers of these cells into draining lymph nodes within 24 h (3, 25).”
ResultCCR7 acts as both a sensor and a sink for CCL19 to coordinate collective leukocyte migration
Alanko, J., Uçar, M. C., Čanigová, N., Stopp, J., Schwarz, J., Merrin, J., Hannezo, É., & Sixt, M. (2023) · Science Immunology · doi:10.1126/sciimmunol.adc9584 · Cited by 73
Plasmacytoid Dendritic Cells Migrate in Afferent Skin Lymph
Pascale, F., Contreras, V., Bonneau, M., Courbet, A., Chilmonczyk, S., Bevilacqua, C., Eparaud, M., Niborski, V., Riffault, S., Balazuc, A., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.180.9.5963 · Cited by 70
“Expression of CCR7 has also been demonstrated on human pDC (54) and it could be involved in pDC trafficking in lymph due to CCL19/CCL21 production by lymphatic endothelial cells (55).”
BackgroundZanoni, I., Foti, M., Ricciardi‐Castagnoli, P., & Granucci, F. (2005) · The Journal of Immunology · doi:10.4049/jimmunol.175.1.286 · Cited by 71
“, migrate to the draining lymph nodes (9, 30) and recruit and activate NK cells (9, 31).”
BackgroundA review of CpGs and their relevance to aquaculture
Carrington, A. C., & Secombes, C. J. (2006) · Veterinary Immunology and Immunopathology · doi:10.1016/j.vetimm.2006.03.015 · Cited by 77
Lympho-geographical concepts in vaccine delivery
Johansen, P., Mohanan, D., Martínez-Gómez, J. M., Kündig, T. M., & Gander, B. A. (2010) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.05.019 · Cited by 74
Dendritic Cell-Based Vaccine Efficacy: Aiming for Hot Spots
Pizzurro, G. A., & Barrio, M. M. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00091 · Cited by 69
“The elicited CD4 T-cell response is proportional to the number of Ag-carrying DCs reaching the LN (71).”
BackgroundFong, F. L. Y., Shah, N. P., Kirjavainen, P., & El-Nezami, H. (2016) · International Reviews of Immunology · doi:10.3109/08830185.2015.1096937 · Cited by 63
“#3 may affect the Peyer’s patches (PPs) and mesenteric lymph nodes (MLNs) in BalB/c mice as observed from an increases in the number of B cells and frequencies of Th 17 and regulatory T cells [39].”
BackgroundHerring, A. C., Falkowski, N. R., Chen, G.-H., McDonald, R. A., Toews, G. B., & Huffnagle, G. B. (2005) · Infection and Immunity · doi:10.1128/iai.73.1.39-49.2005 · Cited by 69
“This increase in antigen-presenting DC correlated with the magnitude and quality of the T-cell immune response (25).”
BackgroundControl of dendritic cell trafficking in lymphatics by chemokines
Johnson, L. A., & Jackson, D. G. (2013) · Angiogenesis · doi:10.1007/s10456-013-9407-0 · Cited by 74
Lymph Nodes and Cancer Metastasis: New Perspectives on the Role of Intranodal Lymphatic Sinuses
Ji, R. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms18010051 · Cited by 72
“Activation of the endothelial cells comprising HEVs and lymphatic sinuses will quickly take place upon inflammatory insult, leading to angiogenesis and lymphangiogenesis and other changes [34,52].”
BackgroundEnhanced Activation of Human Dendritic Cells by Inducible CD40 and Toll-like Receptor-4 Ligation
Lapteva, N., Seethammagari, M. R., Hanks, B. A., Jiang, J., Levitt, J. M., Slawin, K. M., & Spencer, D. M. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0833 · Cited by 77
Enhancement of Immunity by a DNA Melanoma Vaccine against TRP2 with CCL21 as an Adjuvant
Yamano, T., Kaneda, Y., Huang, S., Hiramatsu, S. H., & Hoon, D. S. �. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.05.018 · Cited by 67
Osteopontin expression by CD103−dendritic cells drives intestinal inflammation
Kourepini, E., Aggelakopoulou, M., Alissafi, T., Paschalidis, N., Simoes, D. C. M., & Panoutsakopoulou, V. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1316447111 · Cited by 66
“S1G), an important molecule for DC migration and homing to lymph node (LN) (42, 43).”
BackgroundLiu, Q., Chen, T., Chen, G., Shu, X., Sun, A., Ma, P., Lu, L., & Cao, X. (2007) · Molecular Immunology · doi:10.1016/j.molimm.2006.12.003 · Cited by 74
Accelerated dendritic-cell migration and T-cell priming in SPARC-deficient mice
Sangaletti, S., Gioiosa, L., Guiducci, C., Rotta, G., Rescigno, M., Stoppacciaro, A., Chiodoni, C., & Colombo, M. P. (2005) · Journal of Cell Science · doi:10.1242/jcs.02474 · Cited by 65
“4C and data not shown), consistent with a recent report (Martin-Fontecha et al., 2003).”
ResultExpression of HLA–B27 causes loss of migratory dendritic cells in a rat model of spondylarthritis
Utriainen, L., Firmin, D., Wright, P., Cerovic, V., Bréban, M., McInnes, I. B., & Milling, S. W. F. (2012) · Arthritis & Rheumatism · doi:10.1002/art.34561 · Cited by 65
“A hallmark of DCs is their sensitivity to their environment; inflammation mediators activate DCs in vitro and in vivo (28-30).”
BackgroundGM-CSF Monocyte-Derived Cells and Langerhans Cells As Part of the Dendritic Cell Family
Lutz, M. B., Strobl, H., Schuler, G., & Romani, N. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01388 · Cited by 74
Biodistribution of radiolabelled human dendritic cells injected by various routes
Quillien, V., Moisan, A., Carsin, A., Lesimple, T., Lefeuvre, C. P., Adamski, H., Bertho, N., Devillers, A., Leberre, C., & Toujas, L. (2005) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-005-1825-9 · Cited by 65
“Indeed, various studies in animals show that increasing the number of DCs injected subcutaneously leads to a saturation phenomenon, whereby only 3% of the injected DCs are found in the nodes [28, 29].”
BackgroundMultifunctional Silica Nanocapsule with a Single Surface Hole
Lim, Y. T., Kim, J. K., Noh, Y., Cho, M. Y., & Chung, B. H. (2008) · Small · doi:10.1002/smll.200800935 · Cited by 64
Lesimple, T., Neidhard, E.-M., Vignard, V., Lefeuvre, C. P., Adamski, H., Labarrière, N., Carsin, A., Monnier, D., Collet, B., Clapisson, G., et al. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-1879 · Cited by 64
Kursar, M., Höpken, U. E., Koch, M., Köhler, A. C., Lipp, M., Kaufmann, S. H. E., & Mittrücker, H. (2005) · The Journal of Experimental Medicine · doi:10.1084/jem.20041204 · Cited by 64
“Furthermore, migration of mature dendritic cells into secondary lymphoid tissues is impaired (3, 6).”
BackgroundSelf-citationNolte, M. A., LeibundGut‐Landmann, S., Joffre, O. P., & Sousa, C. R. E. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070325 · Cited by 72
Personalized Dendritic Cell-Based Tumor Immunotherapy
Janikashvili, N., Larmonier, N., & Katsanis, E. (2009) · Immunotherapy · doi:10.2217/imt.09.78 · Cited by 68
“Enhancement of DC migratory capacities could be obtained by preadministration of TLR ligands (that additionally support DC activation in vivo) or proinflammatory cytokines that increase CCL21, the ligand of CCR7 expressed by activated DCs and that direct their homing to the draining lymph nodes [11,59].”
BackgroundMigration of dendritic cells to the lymph nodes and its enhancement to drive anti-tumor responses
Seyfizadeh, N., Muthuswamy, R., Mitchell, D. A., Nierkens, S., & Seyfizadeh, N. (2016) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2016.09.002 · Cited by 66
Mechanisms for fast cell migration in complex environments
Vargas, P., Barbier, L., Sáez, P. J., & Piel, M. (2017) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2017.04.007 · Cited by 63
Tetraspanins as Organizers of Antigen-Presenting Cell Function
Sáiz, M. L., Rocha‐Perugini, V., & Sánchez‐Madrid, F. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01074 · Cited by 68
TRPML Cation Channels in Inflammation and Immunity
Spix, B., Chao, Y., Abrahamian, C., Chen, C., & Grimm, C. M. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00225 · Cited by 65
Immunity to Melanoma Antigens: From Self‐Tolerance to Immunotherapy
Slingluff, C. L., Chianese‐Bullock, K. A., Bullock, T. N. J., Grosh, W. W., Mullins, D. W., Nichols, L. A., Olson, W. C., Petroni, G. R., Smolkin, M. E., & Engelhard, V. H. (2006) · Advances in immunology · doi:10.1016/s0065-2776(06)90007-8 · Cited by 65
Dendritic Cells Require the NF-κB2 Pathway for Cross-Presentation of Soluble Antigens
Lind, E. F., Ahonen, C. L., Wasiuk, A., Kosaka, Y., Becher, B., Bennett, K. A., & Noelle, R. J. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.1.354 · Cited by 63
“Because an inability to migrate appropriately to these cytokines would globally impact on the development of CMI in mice (29, 30), studies were executed to evaluate the ability of DC to traffic to defined histological sites following triggering with TLR agonists in vivo.”
BackgroundTargeting of 111In-Labeled Dendritic Cell Human Vaccines Improved by Reducing Number of Cells
Aarntzen, E. H. J. G., Srinivas, M., Bonetto, F. J., Cruz, L. J., Verdijk, P., Schreibelt, G., van de Rakt, M. W. M. M., Lesterhuis, W. J., van Riel, M., Punt, C. J. A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1879 · Cited by 66
Prostaglandin E2 Promotes the Survival of Bone Marrow-Derived Dendritic Cells
Vassiliou, E. K., Sharma, V., Jing, H., Sheibanie, F., & Ganea, D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6955 · Cited by 62
“Therefore, we chose an experimental system in which migration is induced by TNF rather than PGE2 (36).”
BackgroundMethodSabado, R. L., & Bhardwaj, N. (2013) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.12125 · Cited by 65
Cell Biology of T Cell Activation and Differentiation
Santana, M. A., & Esquivel-Guadarrama, F. R. (2006) · International review of cytology · doi:10.1016/s0074-7696(06)50006-3 · Cited by 83
Nakamoto, Y., Mizukoshi, E., Kitahara, M., Arihara, F., Sakai, Y., Kakinoki, K., Fujita, Y., Marukawa, Y., Kazumori, A. R. A. I., Yamashita, T., et al. (2010) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2010.04246.x · Cited by 65
Chatziandreou, N., Farsakoglu, Y., Palomino‐Segura, M., D’Antuono, R., Pizzagalli, D. U., Sallusto, F., Kornek, M., Uguccioni, M., Corti, D., Turley, S. J., et al. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.02.026 · Cited by 63
“Moreover, we observed that SSM death occurs within the first 3 hr after vaccination, much earlier than the time required for DCs to migrate to the LN (Martı́n-Fontecha et al., 2003), and we could not observe any recruitment of migratory DCs expressing CD103 in the LN at 12 hr p.v.”
Self-citationMaximizing dendritic cell migration in cancer immunotherapy
Verdijk, P., Aarntzen, E. H. J. G., Punt, C. J. A., de Vries, I. J. M., & Figdor, C. G. (2008) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.8.7.865 · Cited by 64
“As described in the previous section, conditioning of the skin injection site, increased the expression of CCL21 in the local lymphatic tissues [42] .”
BackgroundChen, S., Wang, Y., Dang, J., Song, N., Chen, X., Wang, J., Huang, G. N., Brown, C. E., Yu, J., Weissman, I. L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-59326-9 · Cited by 65
“It ’ s noteworthy that only a minor fraction of sub-cutaneous administrated bone marrow-derived DCs can migrate into draining lymph nodes 95 .”
Höpken, U. E., Droese, J., Li, J., Joergensen, J., Breitfeld, D., Zerwes, H., & Lipp, M. (2004) · European Journal of Immunology · doi:10.1002/eji.200324690 · Cited by 58
Self-citationFOXO1 Regulates Dendritic Cell Activity through ICAM-1 and CCR7
Dong, G., Wang, Y., Xiao, W., Pacios, S., Xu, F., Tian, C., Xiao, E., Choi, Y., & Graves, D. T. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1401754 · Cited by 59
“After labeling with either 5 mM CFSE (eBioscience) or 10 mM 5- and 6-(4-chloromethyl)benzoyl-amino-tetramethylrhodamine (CMTMR; Life Technologies), a mixture of 10(6) CFSE-labeled DCs and 10(6) CMTMRlabeled DCs was administered by retro-orbital injection into wild-type C57BL/6 recipient mice, as previously described (…”
MethodThe role of the lymphatic system in vaccine trafficking and immune response
Pal, I., & Ramsey, J. D. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2011.05.018 · Cited by 65
Höpken, U. E., Achtman, A. H., Krüger, K., & Lipp, M. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.1203643 · Cited by 59
“Besides regulating lymphoid system homeostasis, these chemokine receptors and their ligands are crucial for the appropriate positioning of naive T cells, B cells, and antigen-bearing dendritic cells within secondary lymphoid organs required for initiating antigen-specific immune responses [3, 12, 13].”
BackgroundSelf-citationGliadin Regulates the NK-Dendritic Cell Cross-Talk by HLA-E Surface Stabilization
Terrazzano, G., Sica, M., Gianfrani, C., Mazzarella, G., Maurano, F., Giulio, B. D., de Saint-Mezard, S., Zanzi, D., Maiuri, L., Londei, M., et al. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.1.372 · Cited by 60
“Because NK cells are present in the GALT (36) and the gut Ag-loaded DCs migrate from GALT to mesenteric lymph nodes (37), the interaction between NK cells and mature DCs could occur in these environments and could contribute to the priming of immune response and to Th1 polarization (18, 35, 38, 39).”
BackgroundDetermining control parameters for dendritic cell‐cytotoxic T lymphocyte interaction
Ludewig, B., Krebs, P., Junt, T., Metters, H., Ford, N. J., Anderson, R. M., & Bocharov, G. A. (2004) · European Journal of Immunology · doi:10.1002/eji.200425085 · Cited by 66
Cellular traffic through afferent lymphatic vessels
Schineis, P., Runge, P., & Halin, C. (2019) · Vascular Pharmacology · doi:10.1016/j.vph.2018.08.001 · Cited by 54
Mansilla, M. J., Hilkens, C. M. U., & Martínez-Cáceres, E. M. (2023) · Immunotherapy Advances · doi:10.1093/immadv/ltad012 · Cited by 57
Narayanan, P., Lapteva, N., Seethammagari, M. R., Levitt, J. M., Slawin, K. M., & Spencer, D. M. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44327 · Cited by 58
“Migration of activated DCs to draining lymph nodes is critical for priming antigen-specific T cells and acts as a chemokine source, which increases lymphocyte recruitment and subsequent proliferation (41, 42).”
BackgroundCCR7-Dependent Immunity during Acute Toxoplasma gondii Infection
Noor, S., Habashy, A., Nance, J. P., Clark, R. T., Nemati, K., Carson, M. J., & Wilson, E. H. (2010) · Infection and Immunity · doi:10.1128/iai.01314-09 · Cited by 70
“These include the generation of thymocytes (6, 26), central and peripheral tolerance, T-cell homeostasis (36), regulatory T-cell (Treg) function (23, 29, 40), and the activation and homing of CCR7-expressing dendritic cells to lymph nodes (12, 28, 32).”
BackgroundThe role of the vascular dendritic cell network in atherosclerosis
Alberts‐Grill, N., Denning, T. L., Rezvan, A., & Jo, H. (2013) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00017.2013 · Cited by 58
“Previous studies have used complicated surgical transplant or cannulation techniques to measure DC migration (142, 190).”
MethodRhee, I., Zhong, M., Reizis, B., Cheong, C., & Veillette, A. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.01369-13 · Cited by 57
“5 M 5- and 6-carboxyfluorescein diacetate succinimidyl ester (CFSE) and 10 M 5- and 6-(((4-chloromethyl)benzoyl)amino)tetramethylrhodamine (CMTMR), respectively, as specified by the manufacturer (Invitrogen) (18).”
BackgroundThe Entry and Egress of Monocytes in Atherosclerosis: A Biochemical and Biomechanical Driven Process
Kang, H., Li, X., Xiong, K., Song, Z., Tian, J., Wen, Y., Sun, A., & Deng, X. (2021) · Cardiovascular Therapeutics · doi:10.1155/2021/6642927 · Cited by 60
“In addition, as wementioned before, inflammatory signaling can induce CCL21a production, for example, subcutaneous injection of IL-1b and TNF-α increased the mRNA level of CCL21 in lymphatic endothelial cells [43].”
BackgroundWalsh, M. P., Duncan, B. B., Larabee, S. M., Krauss, A. C., Davis, J. P. E., Cui, Y., Kim, S. Y., Guimond, M., Bachovchin, W. W., & Fry, T. J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058860 · Cited by 56
“Previous work has shown that the CCR7-CCL19/CCL21 axis is a major contributor to this process [48,49].”
BackgroundTargeting of the Cancer-Associated Fibroblast—T-Cell Axis in Solid Malignancies
Harryvan, T. J., Verdegaal, E. M. E., Hardwick, J. C. H., Hawinkels, L. J. A. C., & van der Burg, S. H. (2019) · Journal of Clinical Medicine · doi:10.3390/jcm8111989 · Cited by 57
Montoya, D. J., & Modlin, R. L. (2010) · Advances in immunology · doi:10.1016/s0065-2776(10)05001-7 · Cited by 85
Vizzardelli, C., Pavelka, N., Luchini, A., Zanoni, I., Bendickson, L., Pelizzola, M., Beretta, O., Foti, M., Granucci, F., Nilsen‐Hamilton, M., et al. (2006) · European Journal of Immunology · doi:10.1002/eji.200535488 · Cited by 52
LILRA2 Activation Inhibits Dendritic Cell Differentiation and Antigen Presentation to T Cells
Lee, D. J., Sieling, P. A., Ochoa, M. T., Krutzik, S. R., Guo, B., Hernandez, M., Rea, T. H., Cheng, G., Colonna, M., & Modlin, R. L. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.12.8128 · Cited by 52
“6B) when stimulated with LILRA2-activated, GM-CSF-treated APCs, while cells receiving an isotype control Ab or GM-CSF alone had robust responses.”
BackgroundInfluentialSabado, R. L., Kavanagh, D. G., Kaufmann, D., Che, K. F., Babcock, E., Rosenberg, E. S., Walker, B. D., Lifson, J. D., Bhardwaj, N., & Larsson, M. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004256 · Cited by 61
“The magnitude and strength of a generated T cell response is based on the quality of the initial priming event, which in turn depends on several factors including trafficking of DCs to lymph node[6] and the quality of the initial DC-T cell interaction[7].”
BackgroundShi, M., Chen, D., Yang, D., & Liu, X. (2015) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-015-0268-9 · Cited by 55
Recent Advances in Polymeric Nanomedicines for Cancer Immunotherapy
Lee, E. S., Shin, J. M., Son, S., Ko, H., Um, W., Song, S. H., Lee, J. A., & Park, J. H. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801320 · Cited by 54
Hooper, C. M., Baltic, S., Misso, N. L. A., Bhoola, K. D., Foster, P. S., Thompson, P. J., & Fogel‐Petrovic, M. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0106055 · Cited by 54
“Following an encounter with antigen, DC undergo a process of maturation, which enhances their antigen-presenting capacity and promotes their migration to lymphoid organs [2, 3], where they induce T cell responses as well as immune tolerance [1, 3].”
BackgroundInfluentialTeijeira, Á., Garasa, S., Peláez, R., Azpilikueta, A., Ochoa, C., Marré, D., Rodrigues, M., Alfaro, C., Aubá, C., Valitutti, S., et al. (2013) · Journal of Investigative Dermatology · doi:10.1038/jid.2013.152 · Cited by 55
“During the maturation/ activation process, DCs change their repertoire of chemokine receptors (i.e., increased CCR7 expression), which enables them to promptly respond to the chemokines secreted by the lymphatic endothelium (i.e., CCL21 and CCL19) (Martin-Fontecha et al., 2003).”
BackgroundPathogenesis and Disease Mechanisms of Occupational Asthma
Lummus, Z. L., Wisnewski, A. V., & Bernstein, D. I. (2011) · Immunology and Allergy Clinics of North America · doi:10.1016/j.iac.2011.07.008 · Cited by 56
Dendritic cells and isolevuglandins in immunity, inflammation, and hypertension
Dixon, K. B., Davies, S. S., & Kirabo, A. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00603.2016 · Cited by 55
Combinatorial drug delivery approaches for immunomodulation
Stewart, J. M., & Keselowsky, B. G. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.013 · Cited by 53
“While DC-based immunotherapy has demonstrated clinical efficacy, administration of exogenously-treated DCs exhibits numerous barriers for widespread implementation including high cost, poor yield, and inefficient DC homing to regional lymph nodes [40,41].”
Chang, W. L. W., Baumgarth, N., Eberhardt, M. K., Lee, C. Y. D., Baron, C. A., Gregg, J. P., & Barry, P. A. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.7794 · Cited by 61
“Discussion The abundance and longevity of migrant Ag-bearing DCs in secondary lymphoid tissues are the key factors in determining the magnitude of the adaptive immune responses (5, 6, 37).”
BackgroundGao, J., Wang, X., Wang, Y., Han, F., Cai, W., Zhao, B., Li, Y., Han, S., Wu, X., & Hu, D. (2016) · Immunology · doi:10.1111/imm.12598 · Cited by 54
Potentiating anti-tumor immunity with physical plasma
Bekeschus, S., Clemen, R., & Metelmann, H. (2018) · Clinical Plasma Medicine · doi:10.1016/j.cpme.2018.10.001 · Cited by 55
Unraveling the Mechanobiology of the Immune System
Kim, J., Shin, Y. J., Ha, L. J., Kim, D., & Kim, D. (2019) · Advanced Healthcare Materials · doi:10.1002/adhm.201801332 · Cited by 53
Metadata
- Authors
- Martín-Fontecha, A., Sebastiani, S., Höpken, U. E., Uguccioni, M., Lipp, M., Lanzavecchia, A., & Sallusto, F.
- Affiliations
- 1Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland
- Institute for Research in Biomedicine (CH)
- 2Max Delbrück Center for Molecular Medicine, 13122 Berlin-Buch, Germany
- Max Delbrück Center (DE)
- Venue
- The Journal of Experimental Medicine
- Publisher
- Rockefeller University Press
- Published
- 2003-08-18
- Volume
- 198
- Issue
- 4
- Pages
- 615-621
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- PMC
- PMC2194169
- OpenAlex
- W2149057253
- Cited by
- 878
- References
- 29
- Citations by year
- 2026: 9 · 2025: 18 · 2024: 16 · 2023: 24 · 2022: 15 · 2021: 28 · 2020: 27 · 2019: 31 · 2018: 33 · 2017: 37 · 2016: 39 · 2015: 28 · 2014: 29 · 2013: 57 · 2012: 30
- FWCI
- 16.54
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- The Journal of Experimental Medicine (publishedVersion)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- MDC Repository (Max-Delbrueck-Center for Molecular Medicine) (acceptedVersion)
- Research Portal (King's College London) (submittedVersion)
- Funders
- National Science Foundation
- Institute for Research in Biomedicine
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (63885)
- Helmut Horten Stiftung
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immunotherapy and Immune Responses
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- dendritic cell migration, draining lymph nodes, CCR7, CCL21, lymphatic endothelial cells, inflammatory cytokines, TNF-α, CD4+ T cell responses, antigen-pulsed dendritic cells, dendritic cell vaccine, lymph node cellularity, tissue inflammation
- MeSH terms
- Animals, Cell Movement, Dendritic Cells, Fluorescent Dyes, Humans, Interleukin-1, Lymph Nodes, Mice, Inbred BALB C, T-Lymphocytes, Tumor Necrosis Factor-alpha, Cell Transplantation, Receptors, Chemokine, Mice, Receptors, CCR7
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.